Teza Capital Management LLC Invests $1.71 Million in Waters Co. (NYSE:WAT)

Teza Capital Management LLC purchased a new stake in shares of Waters Co. (NYSE:WAT - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 4,604 shares of the medical instruments supplier's stock, valued at approximately $1,708,000.

A number of other institutional investors have also bought and sold shares of WAT. Barclays PLC boosted its position in Waters by 34.8% during the third quarter. Barclays PLC now owns 159,995 shares of the medical instruments supplier's stock valued at $57,579,000 after acquiring an additional 41,339 shares during the last quarter. Wedmont Private Capital bought a new stake in Waters during the fourth quarter valued at $202,000. Park Avenue Securities LLC boosted its position in Waters by 19.8% during the fourth quarter. Park Avenue Securities LLC now owns 2,531 shares of the medical instruments supplier's stock valued at $939,000 after acquiring an additional 419 shares during the last quarter. Procyon Advisors LLC boosted its position in Waters by 49.9% during the fourth quarter. Procyon Advisors LLC now owns 994 shares of the medical instruments supplier's stock valued at $369,000 after acquiring an additional 331 shares during the last quarter. Finally, Avanza Fonder AB bought a new stake in Waters during the fourth quarter valued at $1,649,000. Institutional investors own 94.01% of the company's stock.

Waters Stock Up 1.0%

NYSE:WAT traded up $3.67 on Tuesday, hitting $362.20. The stock had a trading volume of 694,743 shares, compared to its average volume of 478,879. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.65 and a current ratio of 0.94. The stock has a market cap of $21.55 billion, a P/E ratio of 33.82, a price-to-earnings-growth ratio of 3.79 and a beta of 1.14. Waters Co. has a 1 year low of $279.24 and a 1 year high of $423.56. The firm's fifty day simple moving average is $346.39 and its two-hundred day simple moving average is $371.27.

Waters (NYSE:WAT - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The medical instruments supplier reported $2.25 EPS for the quarter, beating the consensus estimate of $2.22 by $0.03. The firm had revenue of $661.71 million during the quarter, compared to analyst estimates of $655.50 million. Waters had a net margin of 21.56% and a return on equity of 46.31%. The company's revenue for the quarter was up 3.9% on a year-over-year basis. During the same quarter last year, the business posted $2.21 EPS. Analysts predict that Waters Co. will post 12.86 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on WAT shares. JPMorgan Chase & Co. increased their price objective on shares of Waters from $380.00 to $390.00 and gave the stock a "neutral" rating in a research report on Thursday, March 6th. Wells Fargo & Company increased their price objective on shares of Waters from $415.00 to $420.00 and gave the stock an "overweight" rating in a research report on Thursday, February 13th. Baird R W raised shares of Waters from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, March 26th. UBS Group cut their price objective on shares of Waters from $415.00 to $360.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 7th. Finally, Scotiabank raised shares of Waters from a "sector perform" rating to a "sector outperform" rating and increased their price objective for the stock from $430.00 to $450.00 in a research report on Thursday, February 13th. Ten equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $390.19.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.